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Summary
Cytostatic factor (CSF) arrests vertebrate eggs in
metaphase of meiosis II through several pathways
that inhibit activation of the anaphase-promoting
complex/cyclosome (APC/C) [1–3]. In Xenopus, the
Mos-MEK1-MAPK-p90Rsk cascade utilizes spindle-
assembly-checkpoint components to effect metaphase
arrest. Another pathway involves cyclin E-Cdk2, and
sustained cyclin E-Cdk2 activity in egg extracts
causes metaphase arrest in the absence of Mos; this
latter finding suggests that an independent pathway
contributes to CSF arrest [4, 5]. Here, we demonstrate
that metaphase arrest with cyclin E-Cdk2, but not with
Mos, requires the spindle-checkpoint kinase monopo-
lar spindles 1 (Mps1), a cyclin E-Cdk2 target that is also
implicated in centrosome duplication [6, 7]. xMps1 is
synthesized and activated during oocyte maturation
and inactivated upon CSF release. In egg extracts,
CSF release by calcium was inhibited by constitutively
active cyclin E-Cdk2 and delayed by wild-type xMps1.
Ablation of cyclin E by antisense oligonucleotides
blocked accumulation of xMps1, suggesting that cy-
clin E-Cdk2 controls Mps1 levels. During meiosis II, ac-
tivated cyclin E-Cdk2 significantly inhibited the APC/C
even in the absence of the Mos-MAPK pathway, but
this inhibition was not sufficient to suppress S phase
between meiosis I and II. These results uniquely place
xMps1 downstream of cyclin E-Cdk2 in mediating
a pathway of APC/C inhibition and metaphase arrest.
Results and Discussion
Cytostatic factor (CSF) arrests vertebrate eggs at meta-
phase of the second meiotic division, and elevated free
calcium at fertilization terminates arrest [1]. Classically
assayed by cleavage arrest of embryonic blastomeres,
CSF is defined as an activity that causes metaphase ar-
rest rather than a single protein or factor (reviewed in
[2, 3]). CSF arrest can be maintained in extracts from
unfertilized eggs, and CSF release into anaphase can be
triggered by addition of calcium to the extracts [8, 9].
One pathway contributing to CSF arrest is initiated by
Mos accumulation during oocyte maturation, and cy-
cling extracts from activated eggs biochemically reca-
pitulate CSF arrest when purified Mos kinase is added
[10]. Depletion-reconstitution experiments show that
*Correspondence: jim.maller@uchsc.eduestablishment of CSF arrest by Mos requires the
MAPK-Erk kinase 1 (MEK1)- mitogen-activated protein
kinase (MAPK)-90 kDa ribosomal protein S6 kinase
(p90Rsk) cascade and the budding uninhibited by benz-
imidazole (Bub) and mitotic-arrest-deficient (Mad) pro-
teins involved in the spindle checkpoint [2, 10].
Cycling egg extracts have identified cyclin E-Cdk2 as
a potential CSF component. Cyclin E-Cdk2 is first syn-
thesized and activated during meiosis II and, like Mos,
can establish metaphase arrest in egg extracts [4, 5,
11]. Upon CSF release by calcium, cyclin E-Cdk2 is tran-
siently inhibited in anaphase by Tyr-15 phosphorylation
of Cdk2 [4, 11, 12]. Constitutively active cyclin E-Cdk2
(Cdk2AF for Thr-14Ala and Tyr-15Phe) blocks calcium-
induced CSF release (anaphase), and in cycling egg ex-
tracts, it is sufficient to cause arrest in metaphase [4, 5].
Importantly, extract arrest occurs without activation of
the Mos pathway [5].
Another pathway of anaphase-promoting complex/
cyclosome (APC/C) inhibition involved in CSF arrest in-
volves Emi2, a protein identified in a two-hybrid screen
for Plx1 interactors. Emi2 can cause metaphase arrest
in cycling egg extracts in which the Mos-MAPK pathway
is absent, indicating that like cyclin E-Cdk2, it is capable
of independent inhibition of the APC/C [5, 13, 14]. The
mechanism of APC/C inhibition by Emi2 is not yet clear
but may involve direct binding of Cdc20 [15].
Metaphase arrest established by CSF and the spindle-
assembly checkpoint are biochemically similar but oc-
cur in different contexts and are regulated by different
signals. Whereas the spindle checkpoint monitors at-
tachment of microtubules to kinetochores or tension
[16], CSF arrest in egg extracts, monitored biochemi-
cally as APC/C inhibition and M phase kinase activity,
can occur in the absence of centrosomes, kinetochores,
and even DNA. Finally, unlike spindle-checkpoint
arrest, CSF arrest is released by calcium, and CSF es-
tablishment and release are unaffected by microtubule
depolymerization.
To study connections among cyclin E-Cdk2, APC/C
inhibition, and metaphase arrest, we have focused on
Mps1 because it has been reported to be a cyclin
E-Cdk2 substrate for centrosome duplication [6] and is
also required for the spindle-assembly checkpoint [7].
We asked whether xMps1 fits the criteria for a CSF com-
ponent [1]. As shown in Figure 1A, xMps1 is absent in
immature (stage VI) oocytes, is synthesized after pro-
gesterone treatment, and is present in mature, CSF-
arrested eggs. After CSF release by calcium, xMps1
electrophoretic mobility increases rapidly (Figure 1A).
Protein phosphatase 1g (PP1g) downshifted wild-type
xMps1 to the same electrophoretic mobility as kinase-
dead xMps1 (Figure 1B). In a kinase assay, wild-type
xMps1 phosphorylated itself and myelin basic protein
(MBP), whereas the kinase-dead enzyme showed no ac-
tivity. Phosphatase treatment dramatically reduced
both autophosphorylation and phosphorylation of
MBP by wild-type xMps1 (Figure 1B). The apparent
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1969Figure 1. xMps1 Is Synthesized and Acti-
vated in Oocytes after Progesterone Treat-
ment and Inactivated in CSF-Arrested
Extracts upon Calcium Addition
(A) Immunoblot of G2-arrested stage VI (stVI)
and progesterone-treated oocytes at GVBD
and meiosis II (MII), with antibodies to cyclin
B2 (upper left) and xMps1 (lower left). After
the addition of calcium, a sample of CSF ex-
tract equivalent to one egg was immunoblot-
ted at the indicated times with antibodies to
cyclin B2 (upper right) and xMps1 (lower
right). Without calcium addition, control ex-
tract samples remained stable throughout
the experiment (not shown).
(B) Immunoblot of 2.5 ng of recombinant
(GST-tagged) kinase-dead (KD) and wild-
type (WT) xMps1 either untreated or treated
with 1 unit of protein phosphatase 1 (PP1g)
(left panel). The xMps1 samples were as-
sayed with g-[32P]-ATP and myelin basic pro-
tein (MBP). An autoradiograph is shown (right
panel).residual activity after phosphatase treatment may re-
flect autoactivation of the enzyme during the assay.
Thus, xMps1 activity is regulated by phosphorylation,
and the electrophoretically retarded form is the active ki-
nase. This pattern of xMps1 expression, activation, and
inactivation is fully consistent with criteria identifying
a CSF component.
xMps1 was immunodepleted from cycling egg ex-
tracts so that its role in establishment of CSF arrest
could be determined. A control extract entered mitosis
after 15 min with high cyclin B2 levels and condensed
chromosomes for 30 min, after which nuclei were in in-
terphase (Figure 2A; see also Figure S1A in the Supple-
mental Data available online). The second mitosis oc-
curred at 90 min and lasted until 135 min, when cyclin
B2 was degraded and interphase nuclei were again ob-
served. The level of xMps1 did not change, but the elec-
trophoretic mobility oscillated with the retarded (active)
form coinciding with mitosis (Figure 2B). When added at
time 0, either GST-Mos or cyclin E-GST-Cdk2AF caused
the extract to stably arrest in M phase (Figure 2A and
Figure S1A). Mos arrested the extract in the first mitosis,
whereas cyclin E-Cdk2AF caused arrest in the second
mitosis [5]. Both arrests were stable until the end of
the experiment at 180 min. For determining whether cy-
clin E-Cdk2 directly inhibited the APC/C or instead
blocked its activation by endogenous xCdc20, purified
xCdc20 was added to a cycling extract arrested by cy-
clin E-Cdk2AF. As shown in Figure S1C, xCdc20 was
able to overcome metaphase arrest by cyclin E-Cdk2AF,
suggesting that there was blockade of APC/C activation
rather than direct inhibition. Arrest at the second cycle
by cyclin E-Cdk2 is reproducible and occurs with all
the criteria of CSF arrest, including metaphase-arrested
spindles with meiotic morphology [5]. If cyclin E-Cdk2 isin a complex that regulates M phase exit, the extract
may need to traverse a cell cycle for a complex to be dis-
sociated and reassembled with cyclin E-Cdk2AF. Im-
portantly, a similar situation was reported previously
for centrosome duplication in egg extracts, in which
only the second and subsequent rounds of duplication
were blocked by inhibition of cyclin E-Cdk2 [17]. Deple-
tion of xMps1 (Figure 2A and Figure S1B) had no effect
on CSF arrest with Mos, but it blocked arrest when cy-
clin E-Cdk2AF was added (Figure 2A and Figure S1A).
Recombinant xMps1 was added to immunodepleted ex-
tracts when cyclin E-Cdk2AF was added. Wild-type but
not kinase-dead xMps1 restored metaphase arrest to
depleted extracts when cyclin E-Cdk2AF was added,
as indicated by stabilized cyclin B2 and condensed
chromosomes (Figure S3). Both GST-WT and GST-
KD-xMps1 were stable after addition (Figure S2). These
results indicate that the kinase activity of xMps1 is re-
quired for metaphase arrest by cyclin E-Cdk2 but not
by Mos.
In mouse cells, the Mps1 protein is unstable and does
not accumulate until cyclin E-Cdk2 is activated at the
G1/S transition [6]. We found that the Cdk inhibitor
p27Xic1 inhibited cyclin E-Cdk2 activity in meiosis II but
had no detectable effect on cyclin B-Cdc2 activity,
which accounts for over 95% of total histone H1 activity
(Figure S4). p27Xic1-injected oocytes appeared to ma-
ture normally and underwent germinal vesicle break-
down (GVBD) at the same time as control oocytes and
to the same extent. The level of xMps1 protein was re-
duced by at least 50 percent in p27Xic1-injected oocytes
(Figure S4B), but they still arrested at meiosis II with high
cyclin B-Cdc2 activity (Figure S4E). This result confirms
the earlier report of Furuno et al. who used a related Cdk
inhibitor, p21Cip1, to inhibit cyclin E-Cdk2 [18] and may
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duced. For complete ablation of cyclin E, oocytes were
injected with morpholino antisense oligonucleotides
against cyclin E prior to progesterone treatment. As
shown in Figure 2C, no cyclin E was detectable at MII,
and, importantly, no xMps1 was present at MII (Fig-
ure 2C). However, CSF arrest still occurred in the ab-
sence of both cyclin E and xMps1, with active MPF indi-
cated by the shifted form of cyclin B2 (Figure 2C) and by
Figure 2. xMps1 Is Required for Metaphase Arrest with Cyclin
E-Cdk2AF but Not with Mos
(A) Cycling extracts. Cyclin B2 immunoblots of extract samples
taken at the indicated times after shifting to 25C to initiate cycling.
The first mitosis was evident at 30 min, and the second was evident
at 90 min. Mock indicates extract depletion with preimmune xMps1
antiserum, whereas xMps1 indicates depletion with xMps1 anti-
bodies.
(B) M phase activation of xMps1. Immunoblot of control, mock-
depleted cycling extracts in panel A with antibodies to xMps1.
Time 0 corresponds to 40 min after ionophore.
(C) Cyclin E-Cdk2 promotes xMps1 accumulation. The upper panel
shows an immunoblot of cyclin E at the indicated stages in proges-
terone-treated oocytes injected with morpholino sense (control) or
cyclin E antisense oligonucleotides. The middle shows an immuno-
blot of xMps1 levels in the same oocytes. The lower panel shows an
immunoblot of cyclin B2 in the same oocytes. The upshifted form of
cyclin B2 is characteristic of active cyclin B-Cdc2 and CSF arrest
(Figure 1).MII oocyte morphology (not shown). CSF arrest also oc-
curred in oocytes in which only xMps1 was ablated by
morpholino antisense oligonucleotides (not shown).
These results imply a link between cyclin E and xMps1
stability as suggested previously by Fisk and Winey
[6], but we cannot at the present time exclude an effect
of cyclin E-Cdk2 on the synthesis of xMps1. The estab-
lishment of CSF arrest in oocytes lacking cyclin E
(Figure 2C) differs from previous results in which CSF
arrest was blocked with nonmorpholino antisense oligo-
nucleotides against Cdk2 [19]. The earlier result was ob-
tained before Xenopus cyclin E was cloned and might
have been a result of other Cdk2 functions, e.g., binding
to RINGO [20] or nonspecific effects of the oligonucleo-
tides or mRNA fragments. Morpholinos do not produce
mRNA fragments, only inhibition of translation, with no
evidence of nonspecific effects. Importantly, a similar
situation has been reported for the role of Mos in oocyte
maturation. Early antisense oligonucleotide experi-
ments repeated in many laboratories ablated Mos and
blocked GVBD in meiosis I; this led to the dogma, held
for many years, that Mos accumulation was required
for meiosis I [21, 22]. However, more recent experiments
with UO126 or morpholino antisense oligonucleotides
have shown that the Mos-MAPK pathway is not required
for meiosis I [23, 24], and the earlier results may have re-
flected nonspecific oligo effects on protein synthesis.
Even though their activities are not required to estab-
lish CSF arrest, both kinases may need to be inactivated
for CSF release. To investigate this point further, we
added calcium and either cyclin E-Cdk2AF or xMps1
to CSF extracts and monitored the level of cyclin B2
and histone H1 kinase activity (Figures 3A and 3B).
Kinase-dead xMps1 had no effect on CSF release, but
wild-type xMps1 significantly delayed CSF release by
calcium (Figure 3B). The extent of the delay was corre-
lated with the time required for dephosphorylation of
added xMps1 after calcium addition (Figure 3B). Cyclin
E-Cdk2AF completely blocked CSF release with calcium
(Figure 3A) as previously reported [4]. Taken together,
these findings tempt us to speculate that the inactiva-
tion of xMps1 is also required for CSF release; this is
a possibility that can only be fully evaluated when a con-
stitutively active form of xMps1 is available.
We asked whether cyclin-E-Cdk2-mediated APC/C
inhibition in vivo is independent of other pathways of
CSF arrest and whether such inhibition is sufficient to
establish CSF arrest. Previous data have shown that
treatment of oocytes with the MEK1 inhibitor UO126 af-
fects the kinetics but not the extent of entry into meiosis
[23]. Earlier experiments also showed that ablation of
Mos after GVBD led to M phase exit and DNA replication
[25]. Oocytes lacking MAPK-pathway activation due to
UO126 treatment exhibit lower activation of histone H1
kinase activity than controls, are unable to sustain mei-
osis after GVBD (MI), and thus lead to cyclin B degra-
dation and entry into S phase [23]. Because cyclin E,
Cdk2 [11], and Emi2 [14] are not synthesized until at
least 2 hr after GVBD, UO126-treated oocytes provide
a system for evaluating the action of cyclin E-Cdk2 in
the absence of other known CSF pathways. Accord-
ingly, oocytes were matured with progesterone in the
presence of U0126 and injected with cyclin E-Cdk2AF
within 10 min of GVBD. UO126 treatment inhibited
Mps1 and CSF Arrest
1971Figure 3. Cyclin E-Cdk2AF Blocks, and Active xMps1 Delays, Release of CSF Arrest
CSF extracts prepared from unfertilized eggs were released from metaphase arrest with calcium in the presence of either cyclin E-GST-Cdk2AF
(A), or wild-type and kinase-dead GST-xMps1 (B). Samples taken at the indicated times were used to measure the kinetics of cyclin B2 degra-
dation (left panels) and histone H1 kinase activity (right panels) during CSF release as indicated. In the absence of calcium (control), extracts
remained arrested in M phase. Extracts were supplemented with 50 nM cyclin E-GST-Cdk2AF or GST alone (control) in (A) and 40 ng/ml of
GST, wild-type (WT) GST-xMps1, or kinase-dead (KD) GST-xMps1 in (B). The lower panel of (B) shows immunoblotting of added kinase-dead
(KD) and wild-type (WT) GST-Mps1 in the same extract samples after calcium addition.MAPK activity and led to exit from M phase after GVBD
as judged by cyclin B degradation and reduced histone
H1 kinase activity ([23] and Figures 4A and 4B). Cyclin
E-Cdk2AF stabilized cyclin B2 levels and histone H1 ki-
nase activity relative to controls in both the absence and
presence of UO126 (Figure 4A). As reported previously
[5], cyclin E-Cdk2AF exhibited APC/C inhibitory activity
in control oocytes such that little or no cyclin B2 degra-
dation or loss of histone H1 kinase activity occurred
between MI and MII (Figures 4A and 4B). Significant sta-
bilization of cyclin B2 and increased histone H1 kinase
activity were also observed in the presence of UO126,indicating that cyclin E-Cdk2 can inhibit the APC/C inde-
pendently of the MAPK pathway (Figures 4A and 4B).
With UO126 treatment, the increased histone H1 kinase
activity and cyclin B2 levels in the oocytes injected with
cyclin E-Cdk2AF were, after anaphase I, at a level near
those in control oocytes that remain in M phase. How-
ever, cyclin B2 levels and histone H1 kinase activity
did not increase by 120 min after GVBD as expected
for establishment of CSF arrest (Figures 4A and 4B). De-
spite the stabilizing effect of cyclin E-Cdk2AF on cyclin
B2 levels (Figure 4A, middle panel) and histone H1 ki-
nase activity (Figure 4B, right panel), UO126-treated
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1972Figure 4. Cyclin E-Cdk2AF Inhibits Cyclin B2 Degradation in the Presence of UO126
(A) Control and UO126 (50 mM)-treated oocytes were microinjected within 10 min of GVBD with either GST or cyclin E-GST-Cdk2AF, collected at
the indicated stages, and immunoblotted for phosphorylated (active) MAPK (left panel), cyclin B2 (middle panel), and Tyr-15 phosphorylated
Cdc2-Cdk2 (right panel).
(B) Total histone H1 kinase activity at the indicated stage of maturation in the oocyte samples blotted in (A).
(C) Autoradiogram of genomic DNA in control and UO126-treated oocytes injected within 10 min of GVBD with 50 nl of a-[32P]-dCTP (3000 Ci/
mmol; 10 mCi/ml) and either GST or cyclin E-GST-Cdk2AF. Oocytes were collected immediately after injection and 4 hr after GVBD. Some oocytes
were transferred to medium containing 100 mg/ml cycloheximide (CHX) as a positive control for exit from meiosis and DNA synthesis [22, 23].oocytes exited meiosis after GVBD and were in inter-
phase, synthesizing DNA, with accumulation of endoge-
nous inactive Tyr15-phosphorylated Cdk complexes
characteristic of S phase (Figures 4A, right panel,
and 4C). These oocytes also exhibited morphological
changes associated with interphase (data not shown).
Figure 4 clearly shows that although cyclin E-Cdk2AF
inhibited the APC/C, this pathway is insufficient to sup-
press S phase and support the MI / II transition. An
analogous result was reported previously for the Mos-
MAPK pathway. In those experiments, microinjection
of cycloheximide immediately after GVBD (which would
prevent synthesis of Emi2 and cyclin E) led to exit from
meiosis [22]. Although endogenous Mos was degraded
during this exit, substantial MAPK-pathway activation
by coinjection of purified recombinant Mos wasinsufficient to maintain M phase [22]. The inability of an
activated MAPK pathway to maintain M phase in isola-
tion supports a model in which multiple pathways of
APC/C inhibition are necessary so that S phase between
meiosis I and II can be suppressed. It is notable that cy-
clin E-Cdk2AF was insufficient for entry into meiosis II
in vivo in the presence of UO126, even though the
same level of exogenous kinase activity could prevent
CSF release (anaphase) by calcium addition to extracts
(Figures 3A, 4A, and 4B). These results are consistent
with the concept of hysteresis in models of cell-cycle
transitions [26].
Our results identify the xMps1 kinase as a necessary
element in the pathway of APC/C inhibition for cyclin
E-Cdk2, but not for Mos, during oocyte maturation.
Mps1 is also a key player in the spindle checkpoint; it
Mps1 and CSF Arrest
1973is localized to kinetochores and promotes kinetochore
recruitment of the Bub and Mad proteins, although
Mps1-checkpoint functions that do not require kineto-
chore binding have also been reported [27]. These func-
tions independent of DNA may be relevant for CSF-
dependent APC/C inhibition, which can be observed in
egg extracts in the absence of DNA.
Supplemental Data
Supplementary Data include Experimental Procedures and four
figures and can be found with this article online at http://www.
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